Breast liposuction: the “scarless reduction”, who it suits and what you give up with it

“Breast reduction without scars” is one of the phrases that works best in medical advertising, and one of the worst explained. The technique exists, it is not a fraud, and for some women it is a reasonable option.

But it has three pieces of small print that are almost never read: it leaves the breast more droopy than before, it is not for every breast and what is aspirated cannot be studied under the microscope. This page develops all three.

⚠️ Watch out for the name: there is another page that talks about breast surgery without visible scars, and it refers to the discreet approaches used for breast augmentation with implants, which is the opposite procedure. It is at breast surgery without visible scars. This page is only about reducing.

What it is exactly

Breast liposuction is what its name says: aspirating the fatty contents of the breast through two small incisions — usually in the inframammary fold or near the armpit — with the same cannulas used in any other liposuction.

The breast is not opened. The nipple is not raised on a pedicle. No skin is removed. The gland is not reshaped. It is only emptied.

And from that come its two real virtues:

• Almost non-existent scars, compared with those of a conventional reduction.
• A less aggressive operation, with less risk of the complications associated with large skin flaps.

Against what a conventional reduction does — removing tissue, repositioning the nipple and trimming skin — explained in the operation step by step.

What the only prospective trial says

It is worth being transparent about the quality of the evidence: it is thin. The reference study was published in 2007 in Plastic and Reconstructive Surgery, and it is still the benchmark prospective trial almost twenty years later.

It included 20 African American women, of whom 17 completed the assessment. It removed an average of 1,075 cc per breast and found:

• A significant fall in breast symptoms and in pain.
• A significant improvement in overall perceived health.

In other words: for relieving the symptoms of weight, it works.

🔑 And now the line that decides everything. The study excluded patients whose main complaint was ptosis — droop. It is not a methodological detail: it is the definition of who the technique is for.

⚠️ With 17 patients, from a single population group and with no comparison against conventional surgery, this study does not allow the conclusion that liposuction is equivalent to a reduction. It allows the conclusion that in selected patients it relieves symptoms.

Why the breast ends up lower, not higher

This is the part the advertising leaves out, and it is the most important on the page. It has a very simple mechanical explanation.

Skin does not shrink on its own. When volume is removed without removing skin, the envelope is too big: the same skin cover is left over considerably less content. And what is inside that envelope, with less to hold it up, descends.

🚨 So it is not that the nipple stays where it was: it drops. The breast empties, gives way, and the nipple — sitting on top of what has been emptied — ends up lower than before the operation. You gain on weight and on volume, and you lose on shape.

There is an indirect check that helps to see it. A Swedish study measured the breasts of 106 women before and after gastric bypass, that is, in the face of a “natural” loss of breast volume: with a 20% reduction in body mass index, breast volume fell by 25% but the sternal notch-to-nipple distance shortened by only 4%.

⚠️ That 4% says exactly what has to be understood: emptying a breast does not raise the nipple. What that study did not measure — because it measured from the breastbone — is the other thing: that the nipple, relative to the fold under the breast, ends up worse placed than before. Which is where droop is really measured. It is developed in lose weight first or reduce first?.

Practical consequence, said without hedging: if your complaint is the weight, liposuction can help you. If your complaint is the droop, this technique makes it worse.

What is lost: the study of the tissue

This is the part of the page you will not find on any commercial website, and it is the most important.

In a conventional reduction the excised tissue can be sent to histopathology. It is not always done — it is worth putting it that way and not another — but the option exists, because what leaves theatre is a whole specimen, with its architecture intact, which is exactly what the pathologist needs to see.

🚨 With liposuction that option does not exist. The aspirated material is discarded: it arrives fragmented and mixed with the infiltrated solution, and analysing it would not have the diagnostic yield of a surgical specimen. It is not that it is studied less well: it is that there is nothing that can properly be studied.

🔑 And that qualification is exactly what makes this section useful. The real choice is not between “a study that is always done” and “one that is not”: it is between being able to ask for it and not being able to. The figures below are the reason why, with a specimen on the table, it is worth asking.

Does it matter? The numbers say it does.

The most complete review. A 2020 meta-analysis pooled 42 studies on the incidence of occult carcinoma in breast reduction specimens. The pooled incidence per specimen:

The difference between the two groups was significant (OR 6.02; p < 0.0001), and the authors expressly call for preoperative radiological screening, information for the patient and histopathology guidelines.

And it is not only cancer. A Brazilian series analysed 783 specimens from reductions in women with no oncological history and found relevant findings in 5.1% — the most frequent being atypical lobular hyperplasia — and 3 invasive carcinomas (0.38%). Two variables multiplied the probability of finding something: being 40 or older (OR 4.73) and the pathologist examining four or more blocks from each specimen (OR 6.69).

🔑 How to read this without panicking or ignoring it. 0.6% is little: it means that in 994 out of every 1,000 women the study will not find a carcinoma. But it is a 0.6% detected for free, as a side effect of an operation you were going to have anyway. Giving it up is a legitimate decision if it is taken informed, and a silent loss if nobody tells you about it.

⚠️ And it rises with age. The risk of relevant findings was multiplied by 4.7 from the age of 40. The older you are, the more this argument weighs.

So who is it for?

Putting it all together, the profile in which this technique makes sense is narrow and fairly specific:

It can make sense if:

• Your main complaint is the weight and the volume, and the shape does not matter to you.
• Your breasts do not droop significantly and the nipple is in a good position — because that is where you start from and it will get worse, not better.
• Your breast is predominantly fatty, not dense and glandular.
• Scars are a decisive factor for you, to the point of accepting a less controlled shape.
• You have understood and accepted the point about the study of the tissue.

It is probably not your technique if:

• Your breasts already droop or the nipple points downwards: this technique makes it worse.
• You are looking for a change of shape, not only of size.
• You have dense breasts or you are young with firm glandular tissue.
• You have a personal history of breast cancer — where the incidence of occult carcinoma rises to 3.4% — or a family history that worries you.
• You are over 40 and value the incidental screening.

What we do here with this technique

It deserves a clear answer, because it is one of the few pages on this site where the honest answer is lukewarm:

🔑 It is performed, but very rarely. It is not an orthodox or routine technique, and it is not for one specific reason: the aesthetic result clearly gets worse. It is considered in particular cases, and only when the patient is very clear about the limitations of the result.

What is true about the promise: there are no reduction scars. The only approaches are those of any liposuction, less than a centimetre long.

⚠️ And what has to be accepted in exchange: a smaller breast, droopier than before, with the nipple lower, and with no possibility of studying the tissue. Anyone accepting that with the information in front of them can have surgery this way. Anyone looking for shape, no.

The aspirated material is discarded. No sample is sent, because it would not have the diagnostic yield of a surgical specimen.

Frequently asked questions

Does breast reduction without scars really exist?

Reduction by liposuction exists, leaving two incisions a few millimetres long instead of the vertical pattern or the inverted T. “Without scars” is a commercial exaggeration; “with minimal scars” is accurate.

How much breast can be removed that way?

In the benchmark prospective trial an average of 1,075 cc per breast was removed. That is not little. What it does not do is remove skin.

Will it lift my breasts?

No, and it is worth saying it in full: it leaves them droopier. Contents are removed but not skin, so the breast is left empty inside the same envelope, gives way, and the nipple ends up lower than before. The benchmark study specifically excluded patients whose main complaint was droop.

Is it safer than a normal reduction?

It is less aggressive and it avoids the complications associated with large skin flaps. In exchange, it controls the shape of the result far less and it gives up the histopathological study of the tissue.

What is this about analysing the tissue?

In a conventional reduction what is excised can be sent to histopathology: it is not always done, but the option exists because a whole specimen comes out. In a meta-analysis of 42 studies, that analysis found an occult carcinoma in 0.6% of women with no history of cancer and in 3.4% of those who did have one. With liposuction that option does not exist: the aspirate is discarded and it would not have the diagnostic yield of a surgical specimen.

So is breast liposuction dangerous?

That is not the conclusion, and dangerous it is not. It is an unorthodox technique, workable in specific cases, in which what you gain is minimal scars and what you lose is shape — the breast ends up droopier — and the possibility of studying the tissue.

Do you do it here?

Yes, but very rarely, and only when the patient is very clear about the limitations of the result. The reason it is exceptional is not safety: it is that the aesthetic result gets worse.

How do I know if I am a candidate?

By examination: how much fat and how much gland your breast has, where your nipple is and what exactly bothers you. It is not something decided from a photograph.

Sources

• Moskovitz MJ, et al. Liposuction breast reduction: a prospective trial in African American women. Plast Reconstr Surg. 2007;119:718-726. First prospective trial of breast reduction by liposuction alone in 20 African American women, of whom 17 completed the assessment; an average of 1,075 cc of tissue per breast was removed and a significant fall in breast-related symptoms and in pain was observed, with a significant improvement in the patients’ overall perceived health; patients whose main complaint was ptosis were excluded from the study. https://pubmed.ncbi.nlm.nih.gov/17230112/
• Fitzpatrick SE, et al. Occult Breast Carcinoma Is More Common in Women Undergoing Breast Reduction after Contralateral Cancer: A Systematic Review and Meta-Analysis. Plast Reconstr Surg. 2020;146:117e-126e. Search of MEDLINE and Embase with no language restriction for studies recording the incidence of occult carcinoma in breast reduction specimens; 42 studies were eligible, of which 29 were analysed quantitatively; the pooled incidence of carcinoma per specimen was higher in women with a history of breast cancer (3.4%; 95% CI 2.2-5.3%) than in women without one (0.6%; 95% CI 0.4-0.8%), and that greater probability was significant when the two populations were compared directly (OR 6.02; 95% CI 3.06-11.86; p < 0.0001); the authors conclude that preoperative radiological screening, patient information and histopathology guidelines are needed. https://pubmed.ncbi.nlm.nih.gov/32740565/
• Usón Junior PLS, et al. Incidental Findings in Reduction Mammoplasty Specimens in Patients with No Prior History of Breast Cancer. An Analysis of 783 Specimens. Pathol Oncol Res. 2018;24:95-99. Review of all histopathology reports from patients who had a breast reduction at a tertiary institution in Brazil between January 2008 and August 2014, excluding a personal history of breast cancer and incomplete reports; of 1,672 specimens, 783 met the inclusion criteria, with a median age of 40 (8-77) and 57% of specimens weighing less than 200 g; “relevant findings” were taken to be flat epithelial atypia, atypical hyperplasia, carcinoma in situ and invasive carcinoma; there were 40 relevant findings (5.1%), the most frequent being atypical lobular hyperplasia, and 3 invasive carcinomas (0.38%); on multivariate analysis, the only variables associated with a greater probability of relevant findings were age of 40 or over (OR 4.73; 95% CI 1.98-11.3; p < 0.001) and examination of 4 or more paraffin blocks per specimen (OR 6.69; 95% CI 2.25-19.9; p < 0.001); the authors note that there are no guidelines on the histopathological assessment of breast reduction specimens. https://pubmed.ncbi.nlm.nih.gov/28391513/
• Ockell J, et al. «Normal» breast dimensions in obese women — reference values and the effect of weight loss. J Plast Reconstr Aesthet Surg. 2024. One hundred and six women who had a Roux-en-Y gastric bypass were measured before and after bariatric surgery; the percentage change in each breast measurement relative to the percentage change in body mass index is predictable: with a 20% reduction in BMI, breast volume falls by 25%, sternal notch-to-nipple distance by 4% and ptosis by 20%. https://pubmed.ncbi.nlm.nih.gov/38810359/

Book your consultation

If you have been offered a “reduction without scars”, there are two questions worth asking before saying yes: “is this going to lift my breasts?” and “what happens to the tissue that is aspirated?”. The honest answers are “no” and “it cannot be studied the way excised tissue can” — and with those two answers on the table, the decision is yours and it is an informed one.

And if your problem is the shape and not only the size, the technique you are looking for is a different one.

Clinical confirmation by the surgeon

Dr Enrique Salmerón González

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4624077

Dr Elena García Vilariño

Specialist in Plastic, Aesthetic and Reconstructive Surgery
Registration no. 46/4624503

Last reviewed: 6 September 2026. This content is for information only and does not replace an individual assessment by a healthcare professional.